Anemocyte is a biotech company active in the field of Cell and Gene Therapies (CGTs). We generate and implement innovation in all steps of product development and manufacturing. Our experience and know -how come from far:

  • 14 years of GMP manufacturing of CGTs and biological drugs
  • 61 years of Contract Manufacturing of Active Pharmaceutical Ingredients within our Group (Holding F.I.S. – >400M$ revenue and > 1800 employees)

Our business includes

  • Process development and GMP capabilities (Somatic Cells, Non-Viral Modified Cells) and High-Quality Plasmid for Viral Vector Manufacturing.
  • Project 2020:  to address up to commercial scale needs (Including manufacturing and use of Viral Vectors for CGTs).
  • Final Filling, finishing and lyophilization of small clinical lots (Phase I-III)
  • Big Data Analysis

We are a Biotech Manufacturing Organization (BMO): a biotech company that addresses CGT needs pro-actively offering one stop shop solutions and fostering exciting innovations

Contact Anemocyte
+39 02 96474804
Visit Website